Chromosome 17 polysomy without human epidermal growth factor receptor 2 amplification does not predict response to lapatinib plus paclitaxel compared with paclitaxel in metastatic breast cancer.
about
The important molecular markers on chromosome 17 and their clinical impact in breast cancerHER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneityChromosome 17 polysomy: correlation with histological parameters and HER2NEU gene amplification.Testing for HER2 in Breast Cancer: A Continuing Evolution.A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.High-density SNP arrays improve detection of HER2 amplification and polyploidy in breast tumorsTrichostatin A suppresses EGFR expression through induction of microRNA-7 in an HDAC-independent manner in lapatinib-treated cells.HER2 assessment by silver in situ hybridization: where are we now?Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status.MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenon.Assessment of HER2 status in invasive breast cancers with increased centromere 17 copy number.Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer.[In situ hybridization in clinical pathology. Significance of polysomy 17 for HER2 determination and genetic tumor heterogeneity in breast cancer].
P2860
Q26859002-8985193D-324C-462D-A44C-54EE2286D43EQ27006811-13F7BF04-7D63-464B-A2B8-9F0F9E32D6B9Q34361300-80E39CB1-D970-4795-AACB-6B93EA72C4E3Q34424285-622D988A-ACBC-48B6-AEE6-BBD8ECE7F35EQ34744122-C4283176-B06F-4999-BEEE-1094CAA72494Q35078859-35D89B2F-3E7C-40B3-B1AF-22707E6D3F9AQ37632279-82560B52-22B8-4E3A-AD5A-70234FA0ABA4Q38314355-11862EF0-753F-4696-9F56-A54588DAD570Q41133771-4418B4EA-EEB0-4085-B184-CB2BB635A933Q42317509-53056D40-DD61-400D-8F14-FBC04C9DE8C2Q54256014-62B60B6C-878D-4F8C-B71B-FFF042BD5473Q54318735-3C674E96-479C-4755-9FFF-1D4655C43629Q54478604-038FA7E8-7127-4812-9645-CB6ECF737BAD
P2860
Chromosome 17 polysomy without human epidermal growth factor receptor 2 amplification does not predict response to lapatinib plus paclitaxel compared with paclitaxel in metastatic breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Chromosome 17 polysomy without ...... l in metastatic breast cancer.
@en
type
label
Chromosome 17 polysomy without ...... l in metastatic breast cancer.
@en
prefLabel
Chromosome 17 polysomy without ...... l in metastatic breast cancer.
@en
P2093
P1476
Chromosome 17 polysomy without ...... el in metastatic breast cancer
@en
P2093
Angela Santiago
Ivonne Villalobos
Leona Downey
Lisa Williams
Maria Koehler
Michael Arbushites
Michael F Press
Robert B Livingston
Roberta Guzman
P304
P356
10.1158/1078-0432.CCR-09-1643
P407
P577
2010-02-09T00:00:00Z